Noticias de TXMD_US

Noticias del mercado

Últimas noticias sobre TXMD_US — 121 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: TXMD_US ✕ 121 resultados
22/04/2026 TXMD_US — vinhcong.tayninh.gov.vn ES ← EN
TXMD (TherapeuticsMD Inc.) El EPS del tercer trimestre de 2023 no alcanza las estimaciones de consenso por un amplio margen, ya que las acciones caen un 0,48 por ciento en las operaciones de hoy. - Ideas de acciones de tendencia

TXMD (TherapeuticsMD Inc.) El EPS del tercer trimestre de 2023 no alcanza las estimaciones de consenso por un amplio margen, ya que las acciones caen un 0,48 por ciento en…

22/04/2026 TXMD_US — news.google.com
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Trending Stock Ideas
22/04/2026 TXMD_US — Stock Titan
TXMD Financials: Income Statement, Balance Sheet & Cash Flow | Therapeuticsmd Inc
22/04/2026 TXMD_US — MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors
20/04/2026 TXMD_US — MarketWatch ES ← EN
Las acciones de TherapeuticsMD Inc. superan a sus competidores en un buen día de negociación
20/04/2026 TXMD_US — MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
18/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.
18/04/2026 TXMD_US — The Legal Advocate
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.
18/04/2026 TXMD_US — The Legal Advocate
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Basic EPS Analysis
18/04/2026 TXMD_US — newser.com
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Investment Signal Network
18/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.
18/04/2026 TXMD_US — thelegaladvocate.com
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Revenue Growth Report
18/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Pro Trader Recommendations
18/04/2026 TXMD_US — newsline.com
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.
18/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading. - Earnings Beat Streak
16/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - High Attention Stocks
16/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Trending Buy Opportunities
16/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Community Chart Signals
16/04/2026 TXMD_US — The Legal Advocate
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Upward Estimate Revision
16/04/2026 TXMD_US — Newser
TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading. - Forward EPS

Página 5 de 7

keyboard_arrow_up